← Back to Screener
Cypherpunk Technologies Inc. Common Stock (CYPH)
Price$0.52
Value ScoreC
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-74.02%
Price vs S&P 500 (4W)-56.39%
VGM Score42.66
Market Capitalization$55.23M
All Metrics
Book Value / Share (Quarterly)$0.90
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.39
Price vs S&P 500 (YTD)-63.43%
Net Profit Margin (TTM)-2705.80%
EPS (TTM)$-0.69
10-Day Avg Trading Volume7.58M
EPS Excl Extra (TTM)$-0.69
EPS (Annual)$-1.80
ROI (Annual)-192.75%
Cash / Share (Quarterly)$0.07
P/E Basic Excl Extra (TTM)26.49x
ROA (Last FY)-137.52%
EBITD / Share (TTM)$-0.29
ROE (5Y Avg)-103.49%
Operating Margin (TTM)-2761.73%
Cash Flow / Share (Annual)$-0.52
P/B Ratio0.65x
P/B Ratio (Quarterly)0.85x
Net Income / Employee (Annual)$-11,259,200
Net Interest Coverage (TTM)-97.81x
ROA (TTM)-80.72%
EPS Incl Extra (Annual)$-1.80
Current Ratio (Annual)35.56x
Quick Ratio (Quarterly)27.02x
3-Month Avg Trading Volume3.35M
52-Week Price Return31.34%
P/E Incl Extra (TTM)26.49x
Revenue / Employee (TTM)$0
P/S Ratio (Annual)36.82x
Asset Turnover (Annual)0.01x
52-Week High$3.70
EPS Excl Extra (Annual)$-1.80
26-Week Price Return-66.09%
Quick Ratio (Annual)35.55x
13-Week Price Return-15.78%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)27.28x
Enterprise Value$48.54M
Asset Turnover (TTM)0.02x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-2707.40%
Cash / Share (Annual)$0.17
3-Month Return Std Dev170.19%
Net Income / Employee (TTM)$-9,484,800
ROE (Last FY)-192.75%
Net Interest Coverage (Annual)-0.06x
EPS Basic Excl Extra (Annual)$-1.80
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.69
ROI (TTM)-92.42%
P/S Ratio (TTM)36.82x
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)6.98%
P/E Ratio (TTM)26.49x
Year-to-Date Return-55.28%
5-Day Price Return-50.59%
EPS Normalized (Annual)$-1.80
ROA (5Y Avg)-82.39%
Net Profit Margin (Annual)-2705.80%
Month-to-Date Return-54.09%
EBITD / Share (Annual)$-1.87
Operating Margin (Annual)-2761.73%
ROI (5Y Avg)-103.49%
P/E Excl Extra (TTM)26.49x
EPS Basic Excl Extra (TTM)$-0.69
P/B Ratio (Annual)0.43x
Pretax Margin (TTM)-2707.40%
Book Value / Share (Annual)$1.83
Price vs S&P 500 (13W)-24.03%
Beta0.20x
Revenue / Share (TTM)$0.00
ROE (TTM)-92.42%
52-Week Low$0.23
vGradeC
mGradeD
vgmGradeC
Show chart for
Analyst Recommendations
Dec 2025
Jan 2026
Feb 2026
Mar 2026
2.17
2.17
2.17
2.17
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CYPHCypherpunk Technologies Inc. Common Stock | C | — | D | $0.52 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Cypherpunk Technologies Inc develops novel therapies for cancer patients while maintaining a digital asset treasury concentrated in Zcash. The company combines oncology research and drug development with cryptocurrency asset management.